Proportions of patients meeting definitions for progressive disease or improvement should be included in clinical trials for systemic sclerosis interstitial lung disease
Related Posts
Linares MA, Liauw D, Cervantes L. The Exam Room as Sanctuary - Caring for Undocumented Patients. N Engl J Med. 2026 Jul 11. doi: 10.1056/NEJMp2603126.[...]
Htoo PT, Cho H, Paik JM, Bykov K, Everett BM, Glynn RJ, Shay C, Schmedt N, Wexler DJ, Patorno E. Cardiovascular outcomes of empagliflozin-GLP-1RA combination[...]
Cheung N, Harmon R, Dietz RL Jr, Chandna S, Shoucri S. Coccidioidal peritonitis: A rare manifestation of disseminated coccidioidomycosis. IDCases. 2026 Jul 5;45:e02674. doi: 10.1016/j.idcr.2026.e02674.[...]